Arax Advisory Partners’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40
Closed -$8.8K 4353
2025
Q3
$8.8K Buy
+40
New +$585 ﹤0.01% 2655

Other funds holding MESO

Arax Advisory Partners's MESO Position: Q1 2026 in Review

Arax Advisory Partners reduced its Mesoblast (MESO) stake by 85% in Q1 2026, selling an estimated $2.37M and leaving 24,425 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #756.

Arax Advisory Partners first reported a position in MESO in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.22M in Q3 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Arax Advisory Partners held 24,425 shares of Mesoblast worth $376K as of Q1 2026.
  • Arax Advisory Partners sold 142,057 Mesoblast shares in Q1 2026, an estimated $2.37M.
  • Mesoblast made up 0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #756 holding.
  • Arax Advisory Partners first reported a position in Mesoblast in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's Mesoblast position peaked at $3.22M in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.